Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4199)
All Articles published online
|
Mar 28, 2006 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Lakatos PL, Fischer S, Lakatos L, Gal I, Papp J. Current concept on the pathogenesis of inflammatory bowel disease-crosstalk between genetic and microbial factors: Pathogenic bacteria and altered bacterial sensing or changes in mucosal integrity take “toll”. World J Gastroenterol 2006; 12(12): 1829-1841 [PMID: 16609988 DOI: 10.3748/wjg.v12.i12.1829] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i12/1829.htm |
| Number | Citing Articles |
| 1 |
Viviana Filpa, Elisabetta Moro, Marina Protasoni, Francesca Crema, Gianmario Frigo, Cristina Giaroni. Role of glutamatergic neurotransmission in the enteric nervous system and brain-gut axis in health and disease. Neuropharmacology 2016; 111: 14 doi: 10.1016/j.neuropharm.2016.08.024
|
| 2 |
Mai Zhang, Robin L. Thurmond, Paul J. Dunford. The histamine H4 receptor: A novel modulator of inflammatory and immune disorders. Pharmacology & Therapeutics 2007; 113(3): 594 doi: 10.1016/j.pharmthera.2006.11.008
|
| 3 |
Béatrice Romier, Yves-Jacques Schneider, Yvan Larondelle, Alexandrine During. Dietary polyphenols can modulate the intestinal inflammatory response. Nutrition Reviews 2009; 67(7): 363 doi: 10.1111/j.1753-4887.2009.00210.x
|
| 4 |
Senka Dobric, Dragan Popovic, Milos Nikolic, Sladjana Andrejevic, Milan Spuran, Branka Bonaci-Nikolic. Anti-neutrophil cytoplasmic antibodies (ANCA) specific for one or several antigens: useful markers for subtypes of ulcerative colitis and associated primary sclerosing cholangitis. Clinical Chemistry and Laboratory Medicine 2012; 50(3) doi: 10.1515/cclm.2011.797
|
| 5 |
Peter Laszlo Lakatos, Erika Hitre, Ferenc Szalay, Kerstin Zinober, Peter Fuszek, Laszlo Lakatos, Simon Fischer, Janos Osztovits, Orsolya Gemela, Gabor Veres, Janos Papp, Peter Ferenci. Common NOD2/CARD15 variants are not associated with susceptibility or the clinicopathologic characteristics of sporadic colorectal cancer in Hungarian patients. BMC Cancer 2007; 7(1) doi: 10.1186/1471-2407-7-54
|
| 6 |
XIAO KE, JINGTUAN CHEN, XIN ZHANG, WENYI FANG, CHUNBO YANG, JUN PENG, YOUQIN CHEN, THOMAS J. SFERRA. Qing Hua Chang Yin attenuates lipopolysaccharide-induced inflammatory response in human intestinal cells by inhibiting NF-κB activation. Experimental and Therapeutic Medicine 2013; 6(1): 189 doi: 10.3892/etm.2013.1071
|
| 7 |
Yves Guigoz, Joël Doré, Eduardo J Schiffrin. The inflammatory status of old age can be nurtured from the intestinal environment. Current Opinion in Clinical Nutrition and Metabolic Care 2008; 11(1): 13 doi: 10.1097/MCO.0b013e3282f2bfdf
|
| 8 |
J. Lamoril, J.-C. Deybach, P. Bouizegarène. Maladie de Crohn et génétique: connaissances actuelles. Immuno-analyse & Biologie Spécialisée 2007; 22(3): 137 doi: 10.1016/j.immbio.2007.01.002
|
| 9 |
Lajos Sándor Kiss, Péter László Lakatos. Prediction of the disease course in inflammatory bowel diseases. Orvosi Hetilap 2010; 151(8): 293 doi: 10.1556/oh.2010.28813
|
| 10 |
Asgar Ergin, Konrad Büssow, Joachim Sieper, Andreas Thiel, Rainer Duchmann, Thomas Adam. Homologous high-throughput expression and purification of highly conserved E coli proteins. Microbial Cell Factories 2007; 6(1) doi: 10.1186/1475-2859-6-18
|
| 11 |
Péter László Lakatos, László Lakatos. Effectiveness of new, once-daily 5-aminosalicylic acid in the treatment of ulcerative colitis. Orvosi Hetilap 2009; 150(9): 397 doi: 10.1556/oh.2009.28555
|
| 12 |
Aleksandra Banaszkiewicz, Andrzej Radzikowski, Piotr Albrecht. Immunisation in children and adolescents with inflammatory bowel disease. Advances in Medical Sciences 2015; 60(1): 144 doi: 10.1016/j.advms.2014.11.003
|
| 13 |
Alexandra M. Vlk, Daniel Prantner, Kari Ann Shirey, Darren J. Perkins, Marguerite S. Buzza, Vivek Thumbigere-Math, Achsah D. Keegan, Stefanie N. Vogel, Alejandro Aballay. M2a macrophages facilitate resolution of chemically-induced colitis in TLR4-SNP mice. mBio 2023; 14(5) doi: 10.1128/mbio.01208-23
|
| 14 |
Peter Laszlo Lakatos, Petra Anna Golovics, Gyula David, Tunde Pandur, Zsuzsanna Erdelyi, Agnes Horvath, Gabor Mester, Mihaly Balogh, Istvan Szipocs, Csaba Molnar, Erzsebet Komaromi, Gabor Veres, Barbara Dorottya Lovasz, Miklos Szathmari, Lajos S Kiss, Laszlo Lakatos. Has There Been a Change in the Natural History of Crohn's Disease? Surgical Rates and Medical Management in a Population-Based Inception Cohort from Western Hungary Between 1977–2009. American Journal of Gastroenterology 2012; 107(4): 579 doi: 10.1038/ajg.2011.448
|
| 15 |
Güray Can, Ahmet Tezel, Hakan Gürkan, Hatice Can, Bülent Yılmaz, Gülbin Ünsal, Ali Rıza Soylu, Hasan Celalettin Ümit. Tyrosine kinase-2 gene polymorphisms are associated with ulcerative colitis and Crohn's disease in Turkish Population. Clinics and Research in Hepatology and Gastroenterology 2015; 39(4): 489 doi: 10.1016/j.clinre.2015.01.005
|
| 16 |
KAZUHIRO MATSUNAGA, TOMOMITSU TAHARA, HISAKAZU SHIROEDA, TOSHIMI OTSUKA, MASAKATSU NAKAMURA, TAKEO SHIMASAKI, NOBUYUKI TOSHIKUNI, NATSUKO KAWADA, TOMOYUKI SHIBATA, TOMIYASU ARISAWA. The *1244 A>G polymorphism of MyD88 (rs7744) is closely associated with susceptibility to ulcerative colitis. Molecular Medicine Reports 2014; 9(1): 28 doi: 10.3892/mmr.2013.1769
|
| 17 |
Lynnette R. Ferguson, Liljana Gentschew. Advanced Nutrition and Dietetics in Gastroenterology. 2014; : 169 doi: 10.1002/9781118872796.ch3.12
|
| 18 |
Łukasz Dembiński, Marcin Dziekiewicz, Aleksandra Banaszkiewicz. Immune Response to Vaccination in Children and Young People With Inflammatory Bowel Disease. Journal of Pediatric Gastroenterology and Nutrition 2020; 71(4): 423 doi: 10.1097/MPG.0000000000002810
|
| 19 |
Peter Laszlo Lakatos. Prevalence, predictors, and clinical consequences of medical adherence in IBD: How to improve it?. World Journal of Gastroenterology 2009; 15(34): 4234-4239 doi: 10.3748/wjg.15.4234
|
| 20 |
Ravi Verma, Vineet Ahuja, Jaishree Paul. Frequency of single nucleotide polymorphisms in NOD1gene of ulcerative colitis patients: a case-control study in the Indian population. BMC Medical Genetics 2009; 10(1) doi: 10.1186/1471-2350-10-82
|
| 21 |
Maria Papp, Istvan Altorjay, Nir Dotan, Karoly Palatka, Ildiko Foldi, Judit Tumpek, Sandor Sipka, Miklos Udvardy, Tamas Dinya, Laszlo Lakatos, Agota Kovacs, Tamas Molnar, Zsolt Tulassay, Pal Miheller, Gary L. Norman, Tamas Szamosi, Janos Papp, Peter L. Lakatos. New Serological Markers for Inflammatory Bowel Disease Are Associated With Earlier Age at Onset, Complicated Disease Behavior, Risk for Surgery, and NOD2/CARD15 Genotype in a Hungarian IBD Cohort. The American Journal of Gastroenterology 2008; 103(3): 665 doi: 10.1111/j.1572-0241.2007.01652.x
|
| 22 |
Anna Giulia Balducci, Gaia Colombo, Giuseppe Corace, Cristina Cavallari, Lorenzo Rodriguez, Francesca Buttini, Paolo Colombo, Alessandra Rossi. Layered lipid microcapsules for mesalazine delayed-release in children. International Journal of Pharmaceutics 2011; 421(2): 293 doi: 10.1016/j.ijpharm.2011.09.043
|
| 23 |
Abdul Hakim Almakadma, Abdelkarim De Vol, Mohamad S. Alabdaljabar, Sarah Aldosari, Ibrahim Muhsen, Omar AlFreihi, Amr Kurdi, Majid Almadi, Fahad Alsohaibani. Complementary and alternative medicine use and its association with medication adherence in inflammatory bowel disease and other gastrointestinal diseases. Saudi Journal of Gastroenterology 2023; 29(4): 233 doi: 10.4103/sjg.sjg_468_22
|
| 24 |
Liljana Gentschew, Lynnette R. Ferguson. Role of nutrition and microbiota in susceptibility to inflammatory bowel diseases. Molecular Nutrition & Food Research 2012; 56(4): 524 doi: 10.1002/mnfr.201100630
|
| 25 |
Tess Briones, Ginger Salvadalena. An Introduction to Genetics and Application to Crohnʼs Disease. Journal of Wound, Ostomy and Continence Nursing 2007; 34(1): 80 doi: 10.1097/00152192-200701000-00012
|
| 26 |
Jürgen Glas, Julia Seiderer, Cornelia Tillack, Simone Pfennig, Florian Beigel, Matthias Jürgens, Torsten Olszak, Rüdiger P. Laubender, Maria Weidinger, Bertram Müller-Myhsok, Burkhard Göke, Thomas Ochsenkühn, Peter Lohse, Julia Diegelmann, Darina Czamara, Stephan Brand, Manfred Kayser. The NOD2 Single Nucleotide Polymorphisms rs2066843 and rs2076756 Are Novel and Common Crohn's Disease Susceptibility Gene Variants. PLoS ONE 2010; 5(12): e14466 doi: 10.1371/journal.pone.0014466
|
| 27 |
Mauro Pinho. A Biologia molecular das doenças inflamatórias intestinais. Revista Brasileira de Coloproctologia 2008; 28(1): 119 doi: 10.1590/S0101-98802008000100018
|
| 28 |
Lone Frier Bovin, JØrn Brynskov, Laszlo Hegedüs, Tine Jess, Claus Henrik Nielsen, Klaus Bendtzen. Gene expression profiling in autoimmune diseases: Chronic inflammation or disease specific patterns?. Autoimmunity 2007; 40(3): 191 doi: 10.1080/08916930701233813
|
| 29 |
Peter Laszlo Lakatos. Use of new once-daily 5-aminosalicylic acid preparations in the treatment of ulcerative colitis: Is there anything new under the sun?. World Journal of Gastroenterology 2009; 15(15): 1799-1804 doi: 10.3748/wjg.15.1799
|
| 30 |
Tomiyasu Arisawa, Tomomitsu Tahara, Tomoyuki Shibata, Mitsuo Nagasaka, Masakatsu Nakamura, Yoshio Kamiya, Hiroshi Fujita, Masahiko Nakamura, Daisuke Yoshioka, Yuko Arima, Masaaki Okubo, Ichiro Hirata, Hiroshi Nakano. The Influence of Polymorphisms of Interleukin-17A and Interleukin-17F Genes on the Susceptibility to Ulcerative Colitis. Journal of Clinical Immunology 2008; 28(1): 44 doi: 10.1007/s10875-007-9125-8
|
| 31 |
Yiorgos Apidianakis, Chrysoula Pitsouli, Norbert Perrimon, Laurence Rahme. Synergy between bacterial infection and genetic predisposition in intestinal dysplasia. Proceedings of the National Academy of Sciences 2009; 106(49): 20883 doi: 10.1073/pnas.0911797106
|
| 32 |
Asgar Ergin, Uta Syrbe, Rebecca Scheer, Andreas Thiel, Thomas Adam, Konrad Büssow, Rainer Duchmann, Martin Zeitz, Joachim Sieper. Impaired Peripheral Th1 CD4+ T Cell Response to Escherichia coli Proteins in Patients with Crohn’s Disease and Ankylosing Spondylitis. Journal of Clinical Immunology 2011; 31(6): 998 doi: 10.1007/s10875-011-9575-x
|
| 33 |
Bobbi Laing, Matthew P. G. Barnett, Gareth Marlow, Noha Ahmed Nasef, Lynnette R. Ferguson. An update on the role of gut microbiota in chronic inflammatory diseases, and potential therapeutic targets. Expert Review of Gastroenterology & Hepatology 2018; 12(10): 969 doi: 10.1080/17474124.2018.1505497
|
| 34 |
Patrícia Reis de Souza, Helioswilton Sales-Campos, Paulo José Basso, Viviani Nardini, Angelica Silva, Fernanda Banquieri, Vanessa Beatriz Freitas Alves, Javier Emílio Lazo Chica, Auro Nomizo, Cristina Ribeiro de Barros Cardoso. Adrenal-Derived Hormones Differentially Modulate Intestinal Immunity in Experimental Colitis. Mediators of Inflammation 2016; 2016: 1 doi: 10.1155/2016/4936370
|
| 35 |
L. Vitetta, D. Briskey, E. Hayes, C. Shing, J. Peake. A review of the pharmacobiotic regulation of gastrointestinal inflammation by probiotics, commensal bacteria and prebiotics. Inflammopharmacology 2012; 20(5): 251 doi: 10.1007/s10787-012-0126-8
|
| 36 |
Nastaran Kordjazy, Arvin Haj-Mirzaian, Arya Haj-Mirzaian, Mohammad Mojtaba Rohani, Erwin W. Gelfand, Nima Rezaei, Amir Hossein Abdolghaffari. Role of toll-like receptors in inflammatory bowel disease. Pharmacological Research 2018; 129: 204 doi: 10.1016/j.phrs.2017.11.017
|
| 37 |
Neogelia Pereira Almeida, Genoile Oliveira Santana, Tamara Celi Almeida, Maria Teresita Bendicho, Denise Carneiro Lemaire, Mauricio Cardeal, André Castro Lyra. Polymorphisms of the cytokine genes TGFB1 and IL10 in a mixed-race population with Crohn’s disease. BMC Research Notes 2013; 6(1) doi: 10.1186/1756-0500-6-387
|
| 38 |
Consensus guidelines for the management of inflammatory bowel disease. Arquivos de Gastroenterologia 2010; 47(3): 313 doi: 10.1590/S0004-28032010000300019
|
| 39 |
Fangyu Wang, Tomomitsu Tahara, Tomiyasu Arisawa, Tomoyuki Shibata, Masakatsu Nakamura, Hiroshi Fujita, Masami Iwata, Yoshio Kamiya, Mitsuo Nagasaka, Kazuya Takahama, Makoto Watanabe, Ichiro Hirata, Hiroshi Nakano. Genetic polymorphisms of CD14 and Toll‐like receptor‐2 (TLR2) in patients with ulcerative colitis. Journal of Gastroenterology and Hepatology 2007; 22(6): 925 doi: 10.1111/j.1440-1746.2007.04909.x
|
| 40 |
A Ergin, T Adam, K Büssow, A Thiel, J Sieper, R Duchmann. Identification of the predominant antigenic epitopes in intestinal flora in IBD. Mucosal Immunology 2008; 1: S19 doi: 10.1038/mi.2008.44
|
| 41 |
Peter Laszlo Lakatos, Zsofia Czegledi, Gyula David, Zsofia Kispal, Lajos S Kiss, Karoly Palatka, Tunde Kristof, Ferenc Nagy, Agnes Salamon, Pal Demeter, Pal Miheller, Tamas Szamosi, Janos Banai, Maria Papp, Laszlo Bene, Agota Kovacs, Istvan Racz, Laszlo Lakatos. Association of adherence to therapy and complementary and alternative medicine use with demographic factors and disease phenotype in patients with inflammatory bowel disease. Journal of Crohn's and Colitis 2010; 4(3): 283 doi: 10.1016/j.crohns.2009.11.011
|
| 42 |
Ernesto Palma, Nicola Costa, Roberto Molinaro, Marco Francardi, Donatella Paolino, Donato Cosco, Massimo Fresta. Improvement of the therapeutic treatment of inflammatory bowel diseases following rectal administration of mesalazine-loaded chitosan microparticles vs Asamax®. Carbohydrate Polymers 2019; 212: 430 doi: 10.1016/j.carbpol.2019.02.049
|
| 43 |
Yue Xiao, Qi Huang, Zherui Wu, Weilin Chen. Roles of protein ubiquitination in inflammatory bowel disease. Immunobiology 2020; 225(6): 152026 doi: 10.1016/j.imbio.2020.152026
|
| 44 |
Peter Laszlo Lakatos, Istvan Altorjay, Tamas Szamosi, Karoly Palatka, Zsuzsanna Vitalis, Judit Tumpek, Sandor Sipka, Miklos Udvardy, Tamas Dinya, Laszlo Lakatos, Agota Kovacs, Tamas Molnar, Zsolt Tulassay, Pal Miheller, Zsolt Barta, Winfried Stocker, Janos Papp, Gabor Veres, Maria Papp. Pancreatic Autoantibodies Are Associated with Reactivity to Microbial Antibodies, Penetrating Disease Behavior, Perianal Disease, and Extraintestinal Manifestations, But Not with NOD2/CARD15 or TLR4 Genotype in a Hungarian IBD Cohort. Inflammatory Bowel Diseases 2009; 15(3): 365 doi: 10.1002/ibd.20778
|
| 45 |
Mengting Luan, Jianing Jin, Ying Wang, Xiaoyuan Li, Anmu Xie. Association of PGLYRP2 gene polymorphism and sporadic Parkinson's disease in northern Chinese Han population. Neuroscience Letters 2022; 775: 136547 doi: 10.1016/j.neulet.2022.136547
|
| 46 |
Peter Laszlo Lakatos, Lajos Sandor Kiss, Karoly Palatka, Istvan Altorjay, Peter Antal-Szalmas, Eszter Palyu, Miklos Udvardy, Tamas Molnar, Klaudia Farkas, Gabor Veres, Jolan Harsfalvi, Janos Papp, Maria Papp. Serum lipopolysaccharide-binding protein and soluble CD14 are markers of disease activity in patients with Crohnʼs disease. Inflammatory Bowel Diseases 2011; 17(3): 767 doi: 10.1002/ibd.21402
|
| 47 |
Aleksandar Vcev, Davorin Pezerovic, Zeljko Jovanovic, Darko Nakic, Ivan Vcev, Ljiljana Majnarić. A retrospective, case-control study on traditional environmental risk factors in inflammatory bowel disease in Vukovar-Srijem County, north-eastern Croatia, 2010. Wiener klinische Wochenschrift 2015; 127(9-10): 345 doi: 10.1007/s00508-015-0741-7
|
| 48 |
Hui Li, Yi Gong, Ying Xie, Qian Sun, Yan Li. Clostridium butyricumprotects the epithelial barrier by maintaining tight junction protein expression and regulating microflora in a murine model of dextran sodium sulfate-induced colitis. Scandinavian Journal of Gastroenterology 2018; 53(9): 1031 doi: 10.1080/00365521.2016.1192678
|
| 49 |
Maria Papp, Istvan Altorjay, Gary L. Norman, Zakera Shums, Karoly Palatka, Zsuzsanna Vitalis, Ildiko Foldi, Gabriella Lakos, Judit Tumpek, Miklos L. Udvardy, Jolan Harsfalvi, Simon Fischer, Laszlo Lakatos, Agota Kovacs, Laszlo Bene, Tamas Molnar, Zsolt Tulassay, Pal Miheller, Gabor Veres, Janos Papp, Peter Laszlo Lakatos. Seroreactivity to microbial components in Crohnʼs disease is associated with ileal involvement, noninflammatory disease behavior and NOD2/CARD15 genotype, but not with risk for surgery in a Hungarian cohort of IBD patients. Inflammatory Bowel Diseases 2007; 13(8): 984 doi: 10.1002/ibd.20146
|
| 50 |
Tamas Szamosi, Janos Banai, Laszlo Lakatos, Zsofia Czegledi, Gyula David, Ferenc Zsigmond, Tunde Pandur, Zsuzsanna Erdelyi, Orsolya Gemela, Maria Papp, Janos Papp, Peter Laszlo Lakatos. Early azathioprine/biological therapy is associated with decreased risk for first surgery and delays time to surgery but not reoperation in both smokers and nonsmokers with Crohnʼs disease, while smoking decreases the risk of colectomy in ulcerative colitis. European Journal of Gastroenterology & Hepatology 2010; 22(7): 872 doi: 10.1097/MEG.0b013e32833036d9
|
| 51 |
Murdani Abdullah, Ari Fahrial Syam, Marcellus Simadibrata, Jeffri Gunawan, Dadang Makmun, Abdul Aziz Rani. New insights on the pathomechanisms of inflammatory bowel disease. Journal of Digestive Diseases 2013; 14(9): 455 doi: 10.1111/1751-2980.12081
|
| 52 |
Daniel L Worthley, Peter G Bardy, David L Gordon, Charles G Mullighan. Mannose-binding lectin and maladies of the bowel and liver. World Journal of Gastroenterology 2006; 12(40): 6420-6428 doi: 10.3748/wjg.v12.i40.6420
|
| 53 |
Hakan Akın, Gülgün Tahan, Filiz Türe, Fatih Eren, Özlen Atuğ, Veysel Tahan, İsmail Hamzaoğlu, Neşe İmeryüz, Nurdan Tözün, Hulya Over Hamzaoglu. Association between bactericidal/permeability increasing protein (BPI) gene polymorphism (Lys216Glu) and inflammatory bowel disease. Journal of Crohn's and Colitis 2011; 5(1): 14 doi: 10.1016/j.crohns.2010.08.008
|
| 54 |
Atsushi Nishiyori, Yasunori Nagakura, Katsuomi Ichikawa. Piroxicam accelerates development of colitis in T-cell receptor α chain-deficient mice. European Journal of Pharmacology 2009; 615(1-3): 241 doi: 10.1016/j.ejphar.2009.05.002
|
| 55 |
T. J. Wilson, M. Jobim, L. Segat, A. M. Bianco, P. H. Salim, P. Portela, L. F. Jobim, D. C. Damin, G. Schwartsmann, R. Roesler, S. Crovella. DEFB1 gene 5′ untranslated region (UTR) polymorphisms are marginally involved in inflammatory bowel disease in south Brazilians. International Journal of Immunogenetics 2014; 41(2): 138 doi: 10.1111/iji.12089
|
| 56 |
Carolina Martins Nascimento, Mateus Campos Casaro, Evelyn Roxana Perez, Willian Rodrigues Ribeiro, Marcia Pinto Alves Mayer, Karin Hitomi Ishikawa, Adriana Lino-dos-Santos-Franco, Joice Naiara Bertaglia Pereira, Caroline Marcantonio Ferreira. Experimental allergic airway inflammation impacts gut homeostasis in mice. Heliyon 2023; 9(6): e16429 doi: 10.1016/j.heliyon.2023.e16429
|
| 57 |
Andrew Szilagyi. Handbook of Prebiotics and Probiotics Ingredients. 2009; doi: 10.1201/9781420062151.ch5
|
| 58 |
Fareeha Zulfiqar, Iztok Hozo, Sneha Rangarajan, Roy A. Mariuzza, Roman Dziarski, Dipika Gupta, Laurel L. Lenz. Genetic Association of Peptidoglycan Recognition Protein Variants with Inflammatory Bowel Disease. PLoS ONE 2013; 8(6): e67393 doi: 10.1371/journal.pone.0067393
|
| 59 |
Ian Shrier, Andrew Szilagyi, José A. Correa. Impact of Lactose Containing Foods and the Genetics of Lactase on Diseases: An Analytical Review of Population Data. Nutrition and Cancer 2008; 60(3): 292 doi: 10.1080/01635580701745301
|
| 60 |
Naoual El Menyiy, Aicha El Allam, Sara Aboulaghras, Imane Jaouadi, Saad Bakrim, Nasreddine El Omari, Mohammad Ali Shariati, Alevtin Miftakhutdinov, Polrat Wilairatana, Mohammad S. Mubarak, Abdelhakim Bouyahya. Inflammatory auto-immune diseases of the intestine and their management by natural bioactive compounds. Biomedicine & Pharmacotherapy 2022; 151: 113158 doi: 10.1016/j.biopha.2022.113158
|
| 61 |
Marc Maresca, Jacques Fantini. Some food-associated mycotoxins as potential risk factors in humans predisposed to chronic intestinal inflammatory diseases. Toxicon 2010; 56(3): 282 doi: 10.1016/j.toxicon.2010.04.016
|
| 62 |
Maria Antonietta Panaro, Vito Carofiglio, Angela Acquafredda, Pasqua Cavallo, Antonia Cianciulli. Anti-inflammatory effects of resveratrol occur via inhibition of lipopolysaccharide-induced NF-κB activation in Caco-2 and SW480 human colon cancer cells. British Journal of Nutrition 2012; 108(9): 1623 doi: 10.1017/S0007114511007227
|
| 63 |
Theodoulakis Christofi, Yiorgos Apidianakis. Ras-oncogenic Drosophila hindgut but not midgut cells use an inflammation-like program to disseminate to distant sites. Gut Microbes 2013; 4(1): 54 doi: 10.4161/gmic.22429
|
| 64 |
Jean Lachaine, Linnette Yen, Catherine Beauchemin, Paul Hodgkins. Medication adherence and persistence in the treatment of Canadian ulcerative colitis patients: analyses with the RAMQ database. BMC Gastroenterology 2013; 13(1) doi: 10.1186/1471-230X-13-23
|
| 65 |
Ranji Hayashi, Tomomitsu Tahara, Hisakazu Shiroeda, Takashi Saito, Masakatsu Nakamura, Mikihiro Tsutsumi, Tomoyuki Shibata, Tomiyasu Arisawa. Influence of IL17A polymorphisms (rs2275913 and rs3748067) on the susceptibility to ulcerative colitis. Clinical and Experimental Medicine 2013; 13(4): 239 doi: 10.1007/s10238-012-0206-5
|
| 66 |
Lauren Ritchie, Stella Taddeo, Brad Weeks, Raymond Carroll, Linda Dykes, Lloyd Rooney, Nancy Turner. Impact of Novel Sorghum Bran Diets on DSS-Induced Colitis. Nutrients 2017; 9(4): 330 doi: 10.3390/nu9040330
|
| 67 |
Shadi Sepehri, Roman Kotlowski, Charles N. Bernstein, Denis O. Krause. Microbial diversity of inflamed and noninflamed gut biopsy tissues in inflammatory bowel disease. Inflammatory Bowel Diseases 2007; 13(6): 675 doi: 10.1002/ibd.20101
|
| 68 |
J. Salfeld, P. Rutgeerts. Biologics in General Medicine. 2007; : 124 doi: 10.1007/978-3-540-29018-6_12
|
| 69 |
Pablo J. Pinedo, Chenguang Wang, Yao Li, D. Owen Rae, Rongling Wu. Risk haplotype analysis for bovine paratuberculosis. Mammalian Genome 2009; 20(2): 124 doi: 10.1007/s00335-008-9167-0
|
| 70 |
László Lakatos, Péter László Lakatos. Changes in the epidemiology of inflammatory bowel diseases. Orvosi Hetilap 2007; 148(5): 223 doi: 10.1556/OH.2007.27906
|
| 71 |
P. L. Lakatos. Pathogenesis and Clinical Practice in Gastroenterology. 2008; 160: 43 doi: 10.1007/978-1-4020-8767-7_6
|
| 72 |
Keith Brew, Percy Tumbale, K. Ravi Acharya. Family 6 Glycosyltransferases in Vertebrates and Bacteria: Inactivation and Horizontal Gene Transfer May Enhance Mutualism between Vertebrates and Bacteria. Journal of Biological Chemistry 2010; 285(48): 37121 doi: 10.1074/jbc.R110.176248
|
| 73 |
Stanislaw J. Gabryszewski, Ofir Bachar, Kimberly D. Dyer, Caroline M. Percopo, Kristin E. Killoran, Joseph B. Domachowske, Helene F. Rosenberg.
Lactobacillus-Mediated Priming of the Respiratory Mucosa Protects against Lethal Pneumovirus Infection. The Journal of Immunology 2011; 186(2): 1151 doi: 10.4049/jimmunol.1001751
|
| 74 |
Petra Anna Golovics, Péter László Lakatos, Gyula Dávid, Tünde Pandur, Zsuzsanna Erdélyi, Ágnes Horváth, Gábor Mester, Mihály Balogh, István Szipocs, Csaba Molnár, Erzsébet Komáromi, Barbara Dorottya Lovász, Miklós Szathmári, Lajos S. Kiss, László Lakatos. The effect of early immunosuppressive therapy on the rate of resections performed in patients with Chron’s disease, in Veszprém county, Hungary, a population-based cohort study. Orvosi Hetilap 2012; 153(14): 541 doi: 10.1556/OH.2012.29331
|
| 75 |
Julien Royet, Dipika Gupta, Roman Dziarski. Peptidoglycan recognition proteins: modulators of the microbiome and inflammation. Nature Reviews Immunology 2011; 11(12): 837 doi: 10.1038/nri3089
|
| 76 |
Lauren E. Ritchie, Stella S. Taddeo, Brad R. Weeks, Florence Lima, Susan A. Bloomfield, M. Andrea Azcarate-Peril, Sara R. Zwart, Scott M. Smith, Nancy D. Turner, Tiffany L. Weir. Space Environmental Factor Impacts upon Murine Colon Microbiota and Mucosal Homeostasis. PLOS ONE 2015; 10(6): e0125792 doi: 10.1371/journal.pone.0125792
|
| 77 |
DOROTA ROSZAK, MIROSŁAWA GAŁĘCKA, WOJCIECH CICHY, PATRYCJA SZACHTA. Qualitative and Quantitative Characteristics of Selected Bacterial Groups in Children with Inflammatory Bowel Diseases. Polish Journal of Microbiology 2016; 65(2): 219 doi: 10.5604/17331331.1204483
|
| 78 |
Sukumar Saha, Xuefang Jing, Shin Yong Park, Shiyong Wang, Xinna Li, Dipika Gupta, Roman Dziarski. Peptidoglycan Recognition Proteins Protect Mice from Experimental Colitis by Promoting Normal Gut Flora and Preventing Induction of Interferon-γ. Cell Host & Microbe 2010; 8(2): 147 doi: 10.1016/j.chom.2010.07.005
|
| 79 |
Peter Laszlo Lakatos, Zsofia Czegledi, Tamas Szamosi, Janos Banai, Gyula David, Ferenc Zsigmond, Tunde Pandur, Zsuzsanna Erdelyi, Orsolya Gemela, Janos Papp, Laszlo Lakatos. Perianal disease, small bowel disease, smoking, prior steroid or early azathioprine/biological therapy are predictors of disease behavior change in patients with Crohn’s disease. World Journal of Gastroenterology 2009; 15(28): 3504-3510 doi: 10.3748/wjg.15.3504
|
| 80 |
Peter Laszlo Lakatos, Laszlo Lakatos. Ulcerative proctitis: a review of pharmacotherapy and management. Expert Opinion on Pharmacotherapy 2008; 9(5): 741 doi: 10.1517/14656566.9.5.741
|
| 81 |
Atsumu Osada, Hiroaki Yamada, Sayuri Takehara, Yuuichiro Tozuka, Taito Fukushima, Hiroyuki Oka, Hiroshi Okazaki, Shohei Nagaoka. Gastrocnemius Myalgia as a Rare Initial Manifestation of Crohn's Disease. Internal Medicine 2018; 57(14): 2001 doi: 10.2169/internalmedicine.0327-17
|
| 82 |
Q. Manyan Fung, Andrew Szilagyi. Carbohydrate Elimination or Adaptation Diet for Symptoms of Intestinal Discomfort in IBD: Rationales for “Gibsons’ Conundrum”. International Journal of Inflammation 2012; 2012: 1 doi: 10.1155/2012/493717
|
| 83 |
Bruna Luísa Radavelli, Priscila Berti Zanella, Amanda Souza Silva, Valesca Dall’Alba. Diet, microbiota and inflammatory bowel disease: review. Nutrition & Food Science 2018; 48(2): 259 doi: 10.1108/NFS-07-2017-0156
|
| 84 |
P. L. Lakatos, I. Altorjay, Y. Mándi, L. Lakatos, J. Tumpek, A. Kovacs, T. Molnar, Z. Tulassay, P. Miheller, K. Palatka, T. Szamosi, S. Fischer, J. Papp, M. Papp. Interaction between seroreactivity to microbial antigens and genetics in Crohn’s disease: is there a role for defensins?. Tissue Antigens 2008; 71(6): 552 doi: 10.1111/j.1399-0039.2008.01049.x
|